Depuy, Inc.: FDA filings under this applicant name
FDA lists 303 510(k) clearances under the applicant name “Depuy, Inc.” (first 1976, latest 2005), plus 4 PMA decisions, across 94 product codes in 9 review panels. Median 510(k) review time under this name: 80 days. Related companies, subsidiaries and acquired businesses that file under other applicant names are counted on their own pages, not here.
Caduvo groups this applicant name under Johnson & Johnson MedTech, based on public ownership records.
510(k) clearances per year
| Year | Clearances | Median review days |
|---|---|---|
| 2012 | 0 | — |
| 2013 | 0 | — |
| 2014 | 0 | — |
| 2015 | 0 | — |
| 2016 | 0 | — |
| 2017 | 0 | — |
| 2018 | 0 | — |
| 2019 | 0 | — |
| 2020 | 0 | — |
| 2021 | 0 | — |
| 2022 | 0 | — |
| 2023 | 0 | — |
| 2024 | 0 | — |
| 2025 | 0 | — |
| 2026 | 0 | — |
Top product codes
| Product code | Device | Submissions | 510(k) clearances |
|---|---|---|---|
| JDI | Prosthesis, Hip, Semi-Constrained, Metal/Polymer, Cemented | 45 | 45 |
| JWH | Prosthesis, Knee, Patellofemorotibial, Semi-Constrained, Cemented, Polymer/Metal/Polymer | 31 | 31 |
| LPH | Prosthesis, Hip, Semi-Constrained, Metal/Polymer, Porous Uncemented | 24 | 24 |
| HWC | Screw, Fixation, Bone | 14 | 14 |
| LZO | Prosthesis, Hip, Semi-Constrained, Metal/Ceramic/Polymer, Cemented Or Non-Porous, Uncemented | 12 | 12 |
| KWP | Appliance, Fixation, Spinal Interlaminal | 11 | 11 |
| KWL | Prosthesis, Hip, Hemi-, Femoral, Metal | 7 | 7 |
| HRY | Prosthesis, Knee, Femorotibial, Semi-Constrained, Cemented, Metal/Polymer | 6 | 6 |
| HSB | Rod, Fixation, Intramedullary And Accessories | 6 | 6 |
| KWQ | Appliance, Fixation, Spinal Intervertebral Body | 6 | 6 |
Plus 84 more product codes.
Review panels
- Orthopedic (261)
- General and Plastic Surgery (13)
- General Hospital (11)
- Dental (5)
- Ophthalmic (3)
- Cardiovascular (2)
- Gastroenterology and Urology (1)
- Neurology (1)
- Physical Medicine (1)
Most recent Depuy, Inc. 510(k) clearances
| 510(k) | Device | Product code | Decision date | Review days |
|---|---|---|---|---|
| K043058 | PINNACLE CONSTRAINED ACETABULAR LINERS | KWZ | 2005-03-14 | 129 |
| K042664 | LPS UPPER EXTREMITY | JDC | 2004-12-08 | 71 |
| K041085 | LPS (LIMB PRESERVATION SYSTEM) LOWER EXTREMITY DOVETAIL INTERCALARY | JWH | 2004-07-22 | 87 |
| K033959 | LPS | JWH | 2004-07-01 | 192 |
| K040544 | DURALOC OPTION ACETABULAR CUP SYSTEM, MODELS 1599-01-044 TO -066, 1599-11-044 TO -062 AND 1599-21-044 TO -062 | LPH | 2004-05-28 | 87 |
| K021478 | DELTA SHOULDER | PHX | 2003-11-18 | 559 |
| K033329 | DEPUY ACE UNIVERSAL AND TROCH ENTRY FEMORAL NAIL SYSTEMS | HSB | 2003-11-14 | 29 |
| K032151 | DEPUY SIGMA TIBIAL INSERTS AND CO-CR TIBIAL TRAYS | JWH | 2003-09-26 | 74 |
| K020541 | AGILITY ANKLE REVISION PROSTHESIS | HSN | 2002-05-20 | 90 |
| K011810 | ORTHOGENESIS LPS PROXIMAL TIBIAL REPLACEMENT AND ORTHOGENESIS LPS TIBIAL BEARING | KRO | 2001-09-07 | 88 |
293 earlier clearances. See the full list in Caduvo.
PMA and De Novo decisions
| Number | Pathway | Device | Decision date |
|---|---|---|---|
| P960001 | PMA | DEPUY 1 BONE CEMENT | 1997-02-11 |
| P910016 | PMA | NEW JERSEY LCS(R) TOTAL KNEE SYSTEM | 1992-10-30 |
| P830055 | PMA | LCS(R) TOTAL KNEE SYSTEM | 1985-04-12 |
| N18466 | PMA | CMW BONE CEMENT | 1984-02-22 |
Recalls
FDA recall records list no recalls under a recalling firm named Depuy, Inc..
224 product recalls in 16 recall events filed under other recalling-firm names cite a 510(k) or PMA held under this applicant name; 1 initiated in the last five years. Most often: Depuy Orthopaedics, Inc. (195), DePuy Orthopaedics, Inc. (27), Mitek Worldwide (2).
These recall records list the clearance number, so the device was cleared under this name. The recalling firm may be the same company under another spelling, a company that acquired the product line, a relabeler or a contract manufacturer. They are not added to the count above.
Recalling firms are matched to this applicant name by name only (same normalization), so related entities that recall under another name are not counted. A recall count says nothing about how safe one company's devices are compared with another's.
Parent company SEC filings
JOHNSON & JOHNSON (JNJ): EDGAR filings, CIK 200406. Caduvo groups Depuy, Inc. under Johnson & Johnson MedTech; the parent's SEC registrant is entered by hand for the group, not matched by name.
Other FDA applicant names starting with the same word
FDA records these as separate applicants. Some may belong to the same corporate group and some may not; their filings are not included in the counts above.
- DePuy Orthopaedics, Inc. (210 510(k)s)
- Depuy Spine, Inc. (71 510(k)s)
- Depuy Mitek, A Johnson & Johnson Company (62 510(k)s)
- Depuy Ireland UC (50 510(k)s)
- DePuy Synthes (20 510(k)s)
- Depuy Mitek (15 510(k)s)
- Depuy(Ireland) (13 510(k)s)
- Depuy Ace Medical Co. (10 510(k)s)
- Depuy Motech Acromed (4 510(k)s)
- Depuy Spine, A Johnson & Johnson Company (4 510(k)s)
- Depuy Mitek, Inc., A Johnson and Johnson Company (3 510(k)s)
- Depuy-Raynham (3 510(k)s)
Frequently asked questions
How many FDA 510(k) clearances are listed under Depuy, Inc.?
FDA lists 303 510(k) clearances under the applicant name “Depuy, Inc.” (first 1976, latest 2005), plus 4 PMA decisions, across 94 product codes in 9 review panels. Filings under other applicant names, such as subsidiaries, are not included.
How long has FDA taken to clear 510(k)s filed by Depuy, Inc.?
The median time from FDA receipt to decision across 510(k)s cleared under the name Depuy, Inc. is 80 days.
Which FDA product codes appear under Depuy, Inc.?
The most frequent FDA product codes under this applicant name are JDI (Prosthesis, Hip, Semi-Constrained, Metal/Polymer, Cemented, 45); JWH (Prosthesis, Knee, Patellofemorotibial, Semi-Constrained, Cemented, Polymer/Metal/Polymer, 31); LPH (Prosthesis, Hip, Semi-Constrained, Metal/Polymer, Porous Uncemented, 24).
Next steps
- See all 303 Depuy, Inc. clearances with predicates and recalls
- Run predicate analysis for product code JDI, Depuy, Inc.'s most frequent
Compiled by Caduvo from public U.S. government records. Counts cover filings under the applicant name shown on this page only. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA or any other agency, or by the companies named. Not regulatory advice. Report an error in this data. Data and corrections policy.